(S)-Cyclopropyl(2-fluorophenyl)methanamine hydrochloride
97%
- Product Code: 113029
CAS:
844470-82-2
| Molecular Weight: | 201.67 g./mol | Molecular Formula: | C₁₀H₁₃ClFN |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22371843 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily used in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of drugs targeting neurological conditions, such as depression, anxiety, or other mood-related disorders. Its structure, featuring a cyclopropyl group and a fluorophenyl moiety, is designed to interact with specific receptors in the brain, potentially enhancing therapeutic efficacy and selectivity. Additionally, it may be investigated for its potential in treating neurodegenerative diseases or as a component in novel psychotropic medications. Its hydrochloride form ensures stability and solubility, making it suitable for formulation into various drug delivery systems.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $283.68 |
+
-
|
| 0.250 | 10-20 days | $528.50 |
+
-
|
| 1.000 | 10-20 days | $1,357.50 |
+
-
|
(S)-Cyclopropyl(2-fluorophenyl)methanamine hydrochloride
This compound is primarily used in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of drugs targeting neurological conditions, such as depression, anxiety, or other mood-related disorders. Its structure, featuring a cyclopropyl group and a fluorophenyl moiety, is designed to interact with specific receptors in the brain, potentially enhancing therapeutic efficacy and selectivity. Additionally, it may be investigated for its potential in treating neurodegenerative diseases or as a component in novel psychotropic medications. Its hydrochloride form ensures stability and solubility, making it suitable for formulation into various drug delivery systems.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :